Feature Reviews in Cardiovascular Diseases, 2nd Edition
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 November 2026 | Viewed by 4289
Editors
Interests: hormones and heart; cardiac failure; insulin resistance; hyperinsulinism; metabolic syndrome; nutraceuticals; pulmonary arterial hypertension; COVID-19
Special Issues, Collections and Topics in MDPI journals
Interests: genetic dyslipidemias; familial hypercholesterolemia; LDL mutations; lipid metabolism; cardiovascular genetics; PCSK9; cardiomyopathies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Despite the progress made in the prevention and treatment of cardiovascular diseases, the number of hospital admissions, healthcare spending, and mortality from cardiovascular causes still rank first in developed and developing countries. However, it must be admitted that cardiovascular diseases are a branch of medicine in which the greatest progress is made every year. Maybe we missed something? One of the topics on which a lot of work has been carried out is heart failure, which is the endpoint of the vast majority of cardiac pathologies. While the situation is sufficiently defined, from a therapeutic point of view, for HF with reduced ejection fraction (HFrEF), this is, unfortunately, not the case for HF with preserved EF (EFpEF), which has been seen to have a prevalence of approximately 50% of forms of HF. Albeit lacking, however, there has been considerable progress both in the knowledge of the pathophysiological mechanisms and in the therapeutic approach of this form of HF. In light of these developments, we have proposed this Special Issue entitled "Feature Reviews in Cardiovascular Diseases, 2nd Edition". It aims to collect the newest and most significant data on cardiovascular research, both in the field of cardiovascular prevention and mechanisms and on therapeutic innovations such as inhibitors of SGLT2 receptors and GLP1 receptor agonists, which have given positive results on adverse cardiovascular outcomes, even regardless of the presence of diabetes.
Dr. Serafino Fazio
Dr. Arturo Cesaro
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular diseases
- heart failure
- cardiac arrhythmias
- metabolic syndrome
- stroke
- pulmonary hypertension
- peripheral artery disease (PAD)
- acute coronary syndrome
- myocarditis
- pericarditis
- valvulopathies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
